Waterdrop Inc. posted strong Q2 2026 results with net operating revenue up 72.8% year-over-year to RMB1.45 billion (US$213.4 million), driven by an 80.5% increase in insurance-related income. Operating profit rose 14.3% year-over-year to RMB111.3 million (US$16.4 million), supported by AI-driven efficiency improvements and new insurance products. The company expanded its medical crowdfunding and digital clinical trial services, while announcing a $10.8 million cash dividend and a new $50 million share repurchase program. These results highlight Waterdrop's growth in insurance and healthcare technology, with AI as a core driver for future expansion.
Supermicro reported a surprising Q4 gross margin of 17.6%, far above guidance, causing shares to jump. However, management revealed this margin spike was largely due to contract deferrals and one-time factors, not a permanent improvement. They foreca...
Waterdrop Inc. reported a 72.8% year-over-year revenue increase to RMB1,448.2 million in Q2 2026 and net profit of RMB125.8 million, marking 18 consecutive profitable quarters. The insurance segment grew 80.5% year-over-year, boosted by AI technology...
Altrova Health has signed an exclusive distribution agreement with U.S.-based Reliability Funding LLC to sell its detection, protection, and wellness products across the United States, marking its entry into the U.S. health market. The distributor wi...
US equity markets fell after a robust August jobs report increased expectations that the Federal Reserve will raise interest rates. This strong jobs data gives the Fed more flexibility to tighten monetary policy to combat inflation. The upcoming Sept...
American Electric Power (AEP) has increased its full-year 2026 operating earnings guidance to $6.25–$6.55 per share, expecting 7–8% annual growth through 2027 and over 9% compound annual growth through 2030. This optimism is driven by strong demand g...
